fda listening session: covid19 impact on rare disease communities
Published 3 years ago • 652 plays • Length 57:12Download video MP4
Download video MP3
Similar videos
-
56:13
a look at rare disease listening sessions with nord and the fda
-
58:25
impact of the covid-19 pandemic on the rare disease community
-
58:27
covid-19 vaccines update: fda and cdc leaders address the rare disease community
-
51:24
continuing the conversation: fda and cdc leaders discuss the covid-19 pandemic and vaccines
-
1:02:43
a rare response: addressing the covid-19 pandemic
-
57:24
natural history studies for rare diseases
-
45:40
mda advocacy institute session 2: covid-19 discussion with the fda
-
45:53
a rare holiday season: tips for mental health wellness during the holidays and the covid-19 pandemic
-
1:03:43
rare disease day 2021 patient panel: how care and research have changed during covid 19
-
6:35
janet woodcock, director cder fda on nord registry program
-
57:50
drug development for rare diseases: a community conversation
-
2:56
susan chittooran's work on rare diseases
-
56:13
health equity and rare disorders
-
7:32:56
fda rare disease day 2023: “intersections with rare diseases – a patient focused event”
-
51:31
fireside chat on impact on rare diseases at fda
-
59:13
nord: advocacy & rare disease
-
1:25:16
rare disease day 2021 | ran north carolina
-
1:01:10
nord membership webinar: activating your medical advisors for covid-19 response
-
1:06:25
your voice matters: how to engage with the fda